STERIS plc $STE Position Raised by Benjamin Edwards Inc.

Benjamin Edwards Inc. lifted its position in shares of STERIS plc (NYSE:STE – Free Report) by 28.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 144,857 shares of the medical equipment provider’s stock after purchasing an additional 31,789 shares during the period. Benjamin Edwards Inc.’s holdings in STERIS were worth $30,428,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in STE. Western Wealth Management LLC purchased a new position in STERIS during the 1st quarter worth approximately $25,000. Compass Financial Management LLC acquired a new stake in shares of STERIS in the third quarter valued at approximately $25,000. Elevation Wealth Partners LLC grew its position in shares of STERIS by 1,130.0% during the second quarter. Elevation Wealth Partners LLC now owns 123 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 113 shares during the last quarter. Trust Co. of Vermont purchased a new position in shares of STERIS during the second quarter worth approximately $41,000. Finally, Community Financial Services Group LLC increased its holdings in shares of STERIS by 50.0% in the 3rd quarter. Community Financial Services Group LLC now owns 216 shares of the medical equipment provider’s stock valued at $45,000 after acquiring an additional 72 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, VP Julia Madsen sold 2,046 shares of the firm’s stock in a transaction that occurred on Friday, November 13th. The shares were sold at an average price of $260.00, for a total transaction of $531,960.00. Following the completion of the transaction, the vice president directly owned 10,211 shares of the company’s stock, valued at $2,654,860. This trade represents a 16.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Mohsen Sohi sold 4,893 shares of the business’s stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $253.22, for a total value of $1,239,005.46. Following the completion of the transaction, the director directly owned 24,305 shares of the company’s stock, valued at approximately $6,154,512.10. This trade represents a 16.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 12,819 shares of company stock worth $3,274,011. Insiders own 1.12% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on STE. Piper Sandler reiterated an “overweight” rating and issued a $275.00 price target (up from $270.00) on shares of STERIS in a research report on Friday, August 7th. Wall Street Zen raised shares of STERIS from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 14th. UBS Group dropped their price objective on shares of STERIS from $275.00 to $270.00 and set a “buy” rating on the stock in a research note on Friday, August 7th. Weiss Ratings raised shares of STERIS from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, November 9th. Finally, Jefferies Financial Group upgraded shares of STERIS from a “hold” rating to a “buy” rating and increased their target price for the stock from $232.00 to $305.00 in a research note on Friday, November 13th. Five analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $283.50.

Read Our Latest Analysis on STERIS

STERIS Stock Up 0.4%

STERIS stock opened at $255.66 on Friday. The firm has a market capitalization of $24.83 billion, a price-to-earnings ratio of 30.33 and a beta of 0.86. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.44 and a current ratio of 2.05. STERIS plc has a fifty-two week low of $195.14 and a fifty-two week high of $269.44. The stock’s fifty day moving average is $227.43 and its two-hundred day moving average is $224.49.

STERIS (NYSE:STE – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The medical equipment provider reported $2.94 EPS for the quarter, topping the consensus estimate of $2.68 by $0.26. The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.56 billion. STERIS had a net margin of 13.41% and a return on equity of 14.80%. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.47 EPS. Analysts predict that STERIS plc will post 11.46 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Tuesday, November 17th will be given a dividend of $0.69 per share. The ex-dividend date is Tuesday, November 17th. This represents a $2.76 dividend on an annualized basis and a yield of 1.1%. STERIS’s payout ratio is presently 32.74%.

STERIS Profile

(Free Report)

STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.

See Also

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.